28053-08-9 UDP-glucose Uridine 5′-diphosphoglucose disodium salt
28053-08-9
Uridine 5′-diphosphoglucose disodium salt
(3,4-Dihydroxytetrahydro-2-furanyl)methyl 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihydrogen diphosphate [ACD/IUPAC Name]
(3,4-Dihydroxytetrahydro-2-furanyl)methyl-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yldihydrogendiphosphat [German] [ACD/IUPAC Name]
248-801-6 [EINECS]
28053-08-9 [RN]
Dihydrogénodiphosphate de (3,4-dihydroxytétrahydro-2-furanyl)méthyle et de 3,4,5-trihydroxy-6-(hydroxyméthyl)tétrahydro-2H-pyran-2-yle [French] [ACD/IUPAC Name]
C1C(C(C(O1)COP(=O)(O)OP(=O)(O)OC2C(C(C(C(O2)CO)O)O)O)O)O
InChI=1S/C11H22O15P2/c12-1-5-8(15)9(16)10(17)11(24-5)25-28(20,21)26-27(18,19)23-3-6-7(14)4(13)2-22-6/h4-17H,1-3H2,(H,18,19)(H,20,21)
ZZAHNEVHQYWAEU-UHFFFAOYSA-N
C15H22N2Na2O17P2
610.26
248-801-6
MFCD20441966
White or almost white powder or crystalline powder
3
Enterprise standard
HPLC/IR
95%min
20%max
85%min
Preserve in tight,light-resistant containers,in a freezing place.
As a active substance of hepatoprotective, UDP-G can enhance liver detoxification function. It plays an irreplace.able role in the treatment of liver damage caused by drugs and can be clinically used for the treatment of toxic and infectious hepatitis. And it can increase endurance for cancer patients undergoing chemotherapy by using 5-FU ,so as to enhance the therapeutic effect.
Also used as pharmaceutical intermediates, and also can be used for the synthesis of oligosaccharide.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View